FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC.

Cancers (Basel) · 2019 · PMC6562954 · PMID 31083571

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

highly significantno p-value reported

A multivariate analysis confirmed that FAM83A and B seem to be robust prognostic markers, with a highly significant negative effect on the overall survival of the patients ( Table 3 ).

also in 132,142 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.